This report contains market size and forecasts of Inflammatory Bowel Disease (IBD) Treatment in Global, including the following market information:
Global Inflammatory Bowel Disease (IBD) Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Inflammatory Bowel Disease (IBD) Treatment market was valued at 13690 million in 2020 and is projected to reach US$ 14950 million by 2027, at a CAGR of 2.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Inflammatory Bowel Disease (IBD) Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Inflammatory Bowel Disease (IBD) Treatment Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Inflammatory Bowel Disease (IBD) Treatment Market Segment Percentages, By Type, 2020 (%)
TNF Inhibitors
Aminosalicyclates
Immunomodulators
Corticosteroids
China Inflammatory Bowel Disease (IBD) Treatment Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Inflammatory Bowel Disease (IBD) Treatment Market Segment Percentages, By Application, 2020 (%)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Global Inflammatory Bowel Disease (IBD) Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Inflammatory Bowel Disease (IBD) Treatment Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Inflammatory Bowel Disease (IBD) Treatment Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Inflammatory Bowel Disease (IBD) Treatment Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
AbbVie
Pfizer
Takeda
Janssen Biotech
Allergan
Bausch Health
Takeda Pharmaceutical
Novartis
Biogen
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Inflammatory Bowel Disease (IBD) Treatment Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Inflammatory Bowel Disease (IBD) Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Inflammatory Bowel Disease (IBD) Treatment Overall Market Size
2.1 Global Inflammatory Bowel Disease (IBD) Treatment Market Size: 2021 VS 2027
2.2 Global Inflammatory Bowel Disease (IBD) Treatment Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Inflammatory Bowel Disease (IBD) Treatment Players in Global Market
3.2 Top Global Inflammatory Bowel Disease (IBD) Treatment Companies Ranked by Revenue
3.3 Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Companies
3.4 Top 3 and Top 5 Inflammatory Bowel Disease (IBD) Treatment Companies in Global Market, by Revenue in 2020
3.5 Global Companies Inflammatory Bowel Disease (IBD) Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Inflammatory Bowel Disease (IBD) Treatment Players in Global Market
3.6.1 List of Global Tier 1 Inflammatory Bowel Disease (IBD) Treatment Companies
3.6.2 List of Global Tier 2 and Tier 3 Inflammatory Bowel Disease (IBD) Treatment Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Inflammatory Bowel Disease (IBD) Treatment Market Size Markets, 2021 & 2027
4.1.2 TNF Inhibitors
4.1.3 Aminosalicyclates
4.1.4 Immunomodulators
4.1.5 Corticosteroids
4.2 By Type - Global Inflammatory Bowel Disease (IBD) Treatment Revenue & Forecasts
4.2.1 By Type - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2016-2021
4.2.2 By Type - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2022-2027
4.2.3 By Type - Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Inflammatory Bowel Disease (IBD) Treatment Market Size, 2021 & 2027
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Online Pharmacy
5.2 By Application - Global Inflammatory Bowel Disease (IBD) Treatment Revenue & Forecasts
5.2.1 By Application - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2016-2021
5.2.2 By Application - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2022-2027
5.2.3 By Application - Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Inflammatory Bowel Disease (IBD) Treatment Market Size, 2021 & 2027
6.2 By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue & Forecasts
6.2.1 By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2016-2021
6.2.2 By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue, 2022-2027
6.2.3 By Region - Global Inflammatory Bowel Disease (IBD) Treatment Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Inflammatory Bowel Disease (IBD) Treatment Revenue, 2016-2027
6.3.2 US Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.3.3 Canada Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.3.4 Mexico Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Inflammatory Bowel Disease (IBD) Treatment Revenue, 2016-2027
6.4.2 Germany Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.4.3 France Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.4.4 U.K. Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.4.5 Italy Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.4.6 Russia Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.4.7 Nordic Countries Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.4.8 Benelux Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Inflammatory Bowel Disease (IBD) Treatment Revenue, 2016-2027
6.5.2 China Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.5.3 Japan Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.5.4 South Korea Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.5.5 Southeast Asia Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.5.6 India Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Inflammatory Bowel Disease (IBD) Treatment Revenue, 2016-2027
6.6.2 Brazil Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.6.3 Argentina Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Inflammatory Bowel Disease (IBD) Treatment Revenue, 2016-2027
6.7.2 Turkey Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.7.3 Israel Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.7.4 Saudi Arabia Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
6.7.5 UAE Inflammatory Bowel Disease (IBD) Treatment Market Size, 2016-2027
7 Players Profiles
7.1 AbbVie
7.1.1 AbbVie Corporate Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
7.1.4 AbbVie Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (2016-2021)
7.1.5 AbbVie Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
7.2.4 Pfizer Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (2016-2021)
7.2.5 Pfizer Key News
7.3 Takeda
7.3.1 Takeda Corporate Summary
7.3.2 Takeda Business Overview
7.3.3 Takeda Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
7.3.4 Takeda Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (2016-2021)
7.3.5 Takeda Key News
7.4 Janssen Biotech
7.4.1 Janssen Biotech Corporate Summary
7.4.2 Janssen Biotech Business Overview
7.4.3 Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
7.4.4 Janssen Biotech Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (2016-2021)
7.4.5 Janssen Biotech Key News
7.5 Allergan
7.5.1 Allergan Corporate Summary
7.5.2 Allergan Business Overview
7.5.3 Allergan Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
7.5.4 Allergan Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (2016-2021)
7.5.5 Allergan Key News
7.6 Bausch Health
7.6.1 Bausch Health Corporate Summary
7.6.2 Bausch Health Business Overview
7.6.3 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
7.6.4 Bausch Health Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (2016-2021)
7.6.5 Bausch Health Key News
7.7 Takeda Pharmaceutical
7.7.1 Takeda Pharmaceutical Corporate Summary
7.7.2 Takeda Pharmaceutical Business Overview
7.7.3 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
7.4.4 Takeda Pharmaceutical Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (2016-2021)
7.7.5 Takeda Pharmaceutical Key News
7.8 Novartis
7.8.1 Novartis Corporate Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
7.8.4 Novartis Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (2016-2021)
7.8.5 Novartis Key News
7.9 Biogen
7.9.1 Biogen Corporate Summary
7.9.2 Biogen Business Overview
7.9.3 Biogen Inflammatory Bowel Disease (IBD) Treatment Major Product Offerings
7.9.4 Biogen Inflammatory Bowel Disease (IBD) Treatment Revenue in Global (2016-2021)
7.9.5 Biogen Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Inflammatory Bowel Disease (IBD) Treatment Market Opportunities & Trends in Global Market
Table 2. Inflammatory Bowel Disease (IBD) Treatment Market Drivers in Global Market
Table 3. Inflammatory Bowel Disease (IBD) Treatment Market Restraints in Global Market
Table 4. Key Players of Inflammatory Bowel Disease (IBD) Treatment in Global Market
Table 5. Top Inflammatory Bowel Disease (IBD) Treatment Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Inflammatory Bowel Disease (IBD) Treatment Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Inflammatory Bowel Disease (IBD) Treatment Revenue Share by Companies, 2016-2021
Table 8. Global Companies Inflammatory Bowel Disease (IBD) Treatment Product Type
Table 9. List of Global Tier 1 Inflammatory Bowel Disease (IBD) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Inflammatory Bowel Disease (IBD) Treatment Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type